US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 57.510
  • +1.830+3.29%
Close Nov 25 16:00 ET
  • 57.510
  • 0.0000.00%
Post 16:20 ET
3.28BMarket Cap4.93P/E (TTM)

Agios Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Agios Pharmaceuticals Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
9.50M
8.96M
-538.09K
Miss Est.
+28.42%
+21.15%
-5.66%
EPS
8.69
16.22
+7.53
Beat Est.
+629.66%
+1089.02%
+86.74%
Analyst Rating
Strong Buy

Nov 25, 2024

Agios Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.302M--
--2024/Q4-- / 9.287M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--
May 2, 20242024/Q18.189M / 8.372M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.302M--
--2024/Q4-- / 9.287M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--
May 2, 20242024/Q18.189M / 8.372M--

Unlock Free Earnings Estimates

Agios Pharmaceuticals Earnings Reports

  • Agios Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 31 09:26 ET

  • Agios Pharmaceuticals | 8-K: Agios Reports Business Highlights and Third Quarter 2024 Financial Results

    Oct 31 07:00 ET

  • Agios Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 09:51 ET

  • Agios Pharmaceuticals | 8-K: Agios Reports Business Highlights and Second Quarter 2024 Financial Results

    Aug 1 07:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 25, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data